Karkucak, M. Et Al. 2021. Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possıble mechanism mediating the suppresing of uveitis attacks.. ARCHIVES OF RHEUMATOLOGY , vol.36, no.1 , 56-62.

Karkucak, M., Kola, M., Kalkışım, A., Çapkın, E., Ayar, A., & Türk, A., (2021). Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possıble mechanism mediating the suppresing of uveitis attacks.. ARCHIVES OF RHEUMATOLOGY , vol.36, no.1, 56-62.

Karkucak, MURAT Et Al. " Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possıble mechanism mediating the suppresing of uveitis attacks.," ARCHIVES OF RHEUMATOLOGY , vol.36, no.1, 56-62, 2021

Karkucak, MURAT Et Al. " Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possıble mechanism mediating the suppresing of uveitis attacks.." ARCHIVES OF RHEUMATOLOGY , vol.36, no.1, pp.56-62, 2021

Karkucak, M. Et Al. (2021) . " Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possıble mechanism mediating the suppresing of uveitis attacks.." ARCHIVES OF RHEUMATOLOGY , vol.36, no.1, pp.56-62.

@article{article, author={MURAT KARKUCAK Et Al. }, title={ Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possıble mechanism mediating the suppresing of uveitis attacks.}, journal={ARCHIVES OF RHEUMATOLOGY}, year=2021, pages={56-62} }